you are here: HomeNewsNovavax
novavax
Jump to
16 Results Found
  • COVID-19 vaccine | Serum Institute may begin Covovax trial on children in July: Report Jun 18, 2021 10:29 AM IST

    COVID-19 vaccine | Serum Institute may begin Covovax trial on children in July: Report

    Novavax has announced promising results from its COVID-19 vaccine candidate’s phase-3 clinical trials in the United States and Mexico

  • COVID-19: Serum Institute yet to receive Novavax vaccine raw materials, launch likely to be delayed Jun 17, 2021 08:33 AM IST

    COVID-19: Serum Institute yet to receive Novavax vaccine raw materials, launch likely to be delayed

    Novavax's COVID-19 vaccine has demonstrated 93 percent effectiveness against novel coronavirus' variants of concern and variants of interest.

  • Covovax: Serum Institute may launch Novavax's COVID-19 vaccine in India by September, says CEO Adar Poonawalla Jun 16, 2021 10:06 AM IST

    Covovax: Serum Institute may launch Novavax's COVID-19 vaccine in India by September, says CEO Adar Poonawalla

    In September 2020, Novavax had announced a manufacturing agreement with the Serum Institute of India for its COVID-19 vaccine candidate NVX-CoV2373.

  • Novavax’s COVID-19 vaccine is 90% effective, study finds Jun 14, 2021 03:38 PM IST

    Novavax’s COVID-19 vaccine is 90% effective, study finds

    Novavax's COVID-19 vaccine demonstrated 93 percent effectiveness against novel coronavirus' variants of concern and variants of interest.

  • COVID-19 crisis | Uttar Pradesh to spend up to $1 billion to buy vaccines, in talks with Pfizer, Sputnik V May 13, 2021 05:54 PM IST

    COVID-19 crisis | Uttar Pradesh to spend up to $1 billion to buy vaccines, in talks with Pfizer, Sputnik V

    The move by Uttar Pradesh, home to more people than Brazil, comes as many Indian states curtail vaccinations due to severe shortages amid a record surge in coronavirus infections, with India recording more than 4,000 deaths for a second straight day as its health system fails to cope.

  • COVID-19: Serum Institute to begin Covovax vaccine's phase 3 trial by mid-May May 04, 2021 03:45 PM IST

    COVID-19: Serum Institute to begin Covovax vaccine's phase 3 trial by mid-May

    The ICMR and SII are jointly performing a phase-2/3 observer-blind, randomised, controlled study to determine the safety and efficacy of the Covovax vaccine.

  • Researchers Are Hatching a Low-Cost Coronavirus Vaccine Apr 06, 2021 09:42 PM IST

    Researchers Are Hatching a Low-Cost Coronavirus Vaccine

    If NDV-HXP-S proves safe and effective, flu vaccine manufacturers could potentially produce well over a billion doses of it a year. Low- and middle-income countries currently struggling to obtain vaccines from wealthier countries may be able to make NDV-HXP-S for themselves or acquire it at low cost from neighbors.

  • Novavax starts allowing participants on placebo to get COVID-19 vaccine in trials Apr 06, 2021 03:39 PM IST

    Novavax starts allowing participants on placebo to get COVID-19 vaccine in trials

    Allowing volunteers to crossover to the active vaccine offers them an incentive to continue in the trials even when other authorized vaccines are available.

  • COVID-19 vaccine update | Indonesia to punish those who refuse to take coronavirus shots Feb 18, 2021 04:53 PM IST

    COVID-19 vaccine update | Indonesia to punish those who refuse to take coronavirus shots

    Though the revised presidential rule has made strict provisions for those who refuse the vaccine by stopping or delaying social assistance programs, the administration has left the final decision of the final sanction to local governments to decide.

  • Novavax COVID-19 vaccine works, but less so against variants Jan 29, 2021 07:55 AM IST

    Novavax COVID-19 vaccine works, but less so against variants

    The announcement comes amid worry about whether a variety of vaccines being rolled out will be strong enough to protect against new variants – and as the world desperately needs new types of shots to boost scarce supplies.

  • Status check on COVID-19 vaccines in pipeline for India over next six months Jan 20, 2021 08:44 PM IST

    Status check on COVID-19 vaccines in pipeline for India over next six months

    In the initial phase, India will inoculate about one crore healthcare workers. This will be followed by two crore frontline workers, police, armed forces, municipal workers, revenue staff and others. In the third phase, 27 crore people above 50 years of age and those with co-morbidities.

  • Pfizer COVID vaccine ready for use in UK: What is India's plan on vaccination? Dec 02, 2020 05:45 PM IST

    Pfizer COVID vaccine ready for use in UK: What is India's plan on vaccination?

    India's COVID-19 vaccination drive will be among the largest in the world and is likely to happen in phases.

  • Novavax delays US COVID-19 vaccine trial again, now sees start in the coming weeks Nov 30, 2020 06:15 PM IST

    Novavax delays US COVID-19 vaccine trial again, now sees start in the coming weeks

    It is the second time that Novavax, which already has a late-stage UK trial underway, has rescheduled the Phase 3 trial after first flagging an October start, hampered by issues in scaling up its manufacturing.

  • Novavax aims for 2 billion COVID-19 vaccine doses under expanded deal with Serum Institute Sep 15, 2020 03:14 PM IST

    Novavax aims for 2 billion COVID-19 vaccine doses under expanded deal with Serum Institute

    Novavax's vaccine is currently in mid-stage trials after an early-stage study showed it produced high levels of antibodies against the novel coronavirus. The company plans to begin late-stage trials in the third quarter.

  • Novavax begins mid-stage study of COVID-19 vaccine in South Africa Aug 17, 2020 02:05 PM IST

    Novavax begins mid-stage study of COVID-19 vaccine in South Africa

    The Phase 2b trial study of NVX-CoV2373 will be conducted on about 2,665 healthy adults and will evaluate the safety and immunogenicity in about 240 medically stable, HIV-positive adults, the company said in a statement.

  • Novavax starts Phase 1 clinical trial of coronavirus vaccine candidate May 26, 2020 11:29 AM IST

    Novavax starts Phase 1 clinical trial of coronavirus vaccine candidate

    The Maryland-based late-stage biotechnology company in April said it identified the candidate, NVX-CoV2373, with which it planned to use its Matrix-M adjuvant to enhance immune responses.

Sections